Your session is about to expire
← Back to Search
SmileyScope VR Group for Overactive Bladder
N/A
Waitlist Available
Led By Raveen Syan, MD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adult patients undergoing elective peripheral nerve evaluation studies for pelvic floor dysfunction
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to one hour post-procedure
Awards & highlights
Study Summary
This trial tests if virtual reality headsets can reduce pain and anxiety in medical procedures.
Eligible Conditions
- Overactive Bladder
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline (pre-pne procedure), up to 1 hour (post-pne procedure)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-pne procedure), up to 1 hour (post-pne procedure)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change In Pain as Measured by Numeric Pain Scale
Change in Anxiety as Measured by State Trait Anxiety Inventory
Secondary outcome measures
Feasibility for the Utilization of the Smiley Scope VR Headset by Likert Scale
Satisfaction with Procedure as measured by Likert Scale
Trial Design
2Treatment groups
Experimental Treatment
Group I: SmileyScope VR GroupExperimental Treatment1 Intervention
Participants in this group will wear the SmileyScope VR set during the PNE procedure for approximately 40 minutes.
Group II: No VR GroupExperimental Treatment1 Intervention
Participants in this group will receive standard of care treatment.
Find a Location
Who is running the clinical trial?
University of MiamiLead Sponsor
899 Previous Clinical Trials
409,732 Total Patients Enrolled
Raveen Syan, MDPrincipal InvestigatorUniversity of Miami
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: SmileyScope VR Group
- Group 2: No VR Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this experimental intervention accepting new participants?
"At present, this specific trial is not enrolling patients. It was first made available on September 30th 2023 and last edited on June 23rd 2023. However, there are currently 67 other studies in need of participants."
Answered by AI
Share this study with friends
Copy Link
Messenger